04/01/2026
Today, April 1st, 2026, the FDA officially approved FOUNDAYO™ (orforglipron), and it’s changing the game for our clinic. Why are we so excited? Because FOUNDAYO™ isn't just another medication—it's freedom.
🚫 NO NEEDLES: A once-daily oral pill.
☕ NO TIMING RULES: Take it anytime, with or without food (no more waiting 30 mins for breakfast!).
🧳 NO REFRIGERATION: Perfect for travel and busy lifestyles.
📉 PROVEN RESULTS: Average weight loss of 12.4% in clinical trials.
"In the ATTAIN-1 trial, individuals taking the highest dose of orforglipron who stayed on treatment lost an average of 27.3 pounds (12.4%) compared to 2.2 pounds (0.9%) with placebo."
Our goal is to find the right tool for your specific biology. We are proud to offer all FDA-approved weight loss options, including:
✅ Zepbound (Injections)
✅ Wegovy (Injections and the Oral Pill)
✅ Non-GLP options for patients who need a different metabolic approach.
While weekly injections still offer the convenience of once-a-week administration and generally higher total weight loss percentages, we are always thrilled when we have more options for our patients.
Cost & Accessibility: Although we are unsure of the exact retail price at this stage, we anticipate it to be lower than current injection prices, making this a potentially more accessible route for many. (Early reports indicate self-pay options may start as low as $149/month).
📍 Contact the clinic today to see if this new oral option is the right fit for your 2026 health goals!
